Krishnaveni Manubolu

Dr. Krishnaveni Manubolu

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2024 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
RPRaveesha Peeriga
Raveesha Peeriga
SAS.A. Mohamed Shiek Arabath
S.A. Mohamed Shiek Arabath
Krishnaveni ManuboluKrishnaveni Manubolu
Krishnaveni Manubolu
BTBency Baby Thelappilly
Bency Baby Thelappilly
LYLakshmi Chakradhar Yarlagadda
Lakshmi Chakradhar Yarlagadda
Biomedical and Pharmacology Journal (BPJ) is an international, open access, peer reviewed, quarterly research journal.

21 October 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
Krishnaveni ManuboluKrishnaveni Manubolu
Krishnaveni Manubolu
RPRaveesha Peeriga
Raveesha Peeriga
Artificial intelligence AI is a sophisticated model or algorithm that has transformed a number of industries, including the medical field. In generative artificial intelligence, content is created using models or algorithms. Generative AI in healthcare revealed numerous new application domains for illness diagnosis. It has given models new outputs that they may use to create unique and fresh content. These can be used to learn new patterns that closely resemble the original data. The models covered in this review article serve as diagnostic tools in a variety of medical imaging applications. Medical specialists use generative AI in medical imaging analysis as a preliminary tool to generate large amounts of data that they can then correlate and extract useful information from. It is widely used in medical imaging, such as x-rays, magnetic resonance imaging, CTscan, COVID, cancer areas are utilized as AI diagnostic tools. Artificial intelligence (AI) has undergone a revolution because of to deep learning, which has made it possible for machines to learn from vast amounts of data and carry out complicated tasks based on that data. One of the most exciting uses of deep learning is in the creation of generative models, which are deep learning models that can produce realistic images, videos, and audio. These models have a variety of uses in the healthcare industry; including imaging. Medical imaging now has a plethora of options because to generative AI, a subfield of AI that focuses on producing original information. With improved patient outcomes, tailored treatment regimens, and greater diagnostic capabilities, it gives healthcare providers more control. Generative AI has transformed medical picture processing, interpretation, and application in clinical practice by harnessing the power of deep learning algorithms. Better diagnosis, New medicine discovery, Personalized medicine Improved medical imaging: The quality of medical images can be raised with the application of generative AI. With the aid of this technology, physicians may be able to diagnose and treat patients early by seeing more detail in images, More effective surgery: Virtual patient models can be produced using generative artificial intelligence, Surgeons can be trained and surgery plans can be made using these models, enhanced rehabilitation ,better mental health care: Chatbots that can provide patients therapy can be developed using generative AI. Medical imaging analysis is a field of healthcare that has revolutionized the way we approach patient care. The ability to examine medical images such as X-rays, CT scans, and MRI scans has allowed doctors and healthcare professionals to gain a better understanding of a patient's condition, monitor their illness, and plan their treatment accordingly. However, with the vast amounts of data produced by medical imaging technology, it is essential to have specialist analysis to retrieve useful information. One of the most significant advancements in medical imaging analysis has been the development of generative image AI models. These models, such as Generative Adversarial Networks (GANs), Variational Autoencoders (VAEs), and Auto encoders, have enabled healthcare professionals to analyze medical images more effectively and efficiently. The GAN model is one of the most popular generative picture AI models. It comprises two neural networks - a generator network and a discriminator network. The discriminator network's primary role is to discern between artificial and real visuals, while the generator network creates synthetic images. In an adversarial training process, the discriminator and generator work together to accurately categorize artificial and real images, with the generator trying to trick the discriminator. This technique has proved useful in radiology, where GANs are used for tasks such as image synthesis, image de-noising, and image segmentation. Image segmentation is a technique used in medical imaging analysis to split an image into several areas or segments. This has proved in identifying specific structures or regions in medical images, such as tumors, blood vessels, or organs. Generative deep models such as VAEs, GANs, and diffusion models have been applied to the augmentation of medical data, providing healthcare professionals with a more comprehensive understanding of a patient's condition. The development of generative image AI models has revolutionized medical imaging analysis, providing healthcare professionals with a more efficient and effective way to analyze medical images. Medical imaging has been a vital tool for healthcare professionals in diagnosing and treating various medical conditions. However, the interpretation of medical images is often challenging due to the complexity of the human body and the variations in anatomical structures. Therefore, image processing techniques are utilised to enhance the quality of medical images and extract relevant information. In this regard, fundamental image processing operations such as image segmentation, registration, and feature extraction are commonly utilised. However, the application of these operations might not always be appropriate due to the intricate structures of medical images, which include various anatomical variations and irregular tumour shapes. In the case of brain imaging, the presence of different tissues and structures, such as grey matter, white matter, and cerebrospinal fluid, can make it challenging to distinguish between healthy and diseased areas. More advanced image processing techniques such as machine learning algorithms are becoming increasingly popular for medical image analysis. The creation of irrelevant images that disturb the logical structure of the image can also occur due to the complexity of medical images. This adversely affect the accuracy of the interpretation of the image, leading to incorrect diagnoses and treatment plans. Hence, there is a need for sophisticated...

11 September 2025 in Current Aging Science
Verified
Journal Article
Closed access
Krishnaveni ManuboluKrishnaveni Manubolu
Krishnaveni Manubolu
RPRaveesha Peeriga
Raveesha Peeriga
Neurodegenerative diseases, including Alzheimer';s, Parkinson';s, and amyotrophic lateral sclerosis (ALS), represent major healthcare challenges worldwide. Despite advances in diagnosis and treatment, these conditions remain incurable, and there is a need for more effective management strategies. The integration of artificial intelligence (AI) in healthcare has emerged as a promising solution, offering new approaches to diagnosis, personalized treatment, and patient care. This paper explores the potential of AI to revolutionize the management of neurodegenerative diseases, with a focus on its synergistic role in pharmacy. By leveraging AI in drug discovery, personalized treatment plans, and clinical decision-making, AI can enhance therapeutic outcomes and improve patient quality of life. The study reviews the current landscape of AI applications in neurodegenerative disease management, with a focus on pharmacy-related interventions. The review includes AI-driven approaches in genomics, biomarkers, drug repurposing, and clinical trials. It also examines AI';s role in optimizing pharmaceutical care, improving medication adherence, and tailoring treatments based on individual genetic profiles. AI has demonstrated its capability to analyze vast datasets, from genetic information to clinical records, to identify novel drug targets and predict patient responses to specific therapies. The use of AI in precision medicine has enabled more accurate diagnosis and has facilitated the development of personalized treatments for neurodegenerative diseases. Additionally, AI tools are enhancing medication management by providing personalized therapy adjustments and improving adherence. AI offers transformative potential for the future of neurodegenerative disease management. Its integration into pharmacy practice promises more effective, individualized treatments, accelerating drug discovery, and optimizing patient care. As AI technologies continue to advance, their role in managing complex neurological disorders will become increasingly vital.

30 June 2025 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
RPRaveesha Peeriga
Raveesha Peeriga
Krishnaveni ManuboluKrishnaveni Manubolu
Krishnaveni Manubolu
VNVenkateshan Narayanan
Venkateshan Narayanan
PKPRASHANTH KUMAR KATTA
PRASHANTH KUMAR KATTA
NJNuraddeen Ibrahim Jaafar
Nuraddeen Ibrahim Jaafar
NSNagul Meeravali Shaik
Nagul Meeravali Shaik
The physiological and immunological profile of children makes pediatric viral infections particularly difficult. Although pediatric populations are a high risk for hospitalization, pediatric-specific antiviral therapy is largely unexplored, resulting in long delays between pediatric drug approvals and commercialization. This chapter discusses inadequacies in the antiviral drug development and administration for pediatric patients and highlights the importance of age specific approaches including regulatory hindrances to approving children's drugs, and the inhumane nature of performing trials in children. The role that Pediatric Research Equity Act (PREA) and the Best Pharmaceuticals for Children Act (BPCA) played in promoting pediatric focused drug research are highlighted. The chapter seeks to encourage cooperation between pediatricians, pharmaceutical developers, and regulatory bodies, in support of the notion that therapeutic antiviral should be truly pediatric centric. Optimizing treatment outcomes is essential to the global health of young patients and these efforts are required.

28 May 2025
Verified
Book Chapter
Closed access
RPRaveesha Peeriga
Raveesha Peeriga
Krishnaveni ManuboluKrishnaveni Manubolu
Krishnaveni Manubolu
Antiviral care is changing by the minute due to technological advancements that improve diagnosis, treatment and prevention of viral diseases. AI, ML, bioinformatics are tools that have allowed for rapid pathogen identification, outbreak models, and drug optiims. CRISPR technologies and next generation sequencing (NGS) allow for diagnostics and therapies to move into the next generation, uncovering viruses and their evolution and resistance particularly in underserved areas. The efficacy of antiviral therapies is enhanced through innovative drug delivery systems including nanotechnology and an mRNA based vaccine develops new standards for a rapid response to viral threats. In this chapter we explore how these cutting edge tools can be integrated toward overcoming existing limitations, increasing care precision, and fostering equitable access to the required antiviral treatments. These technologies will allow us to reduce the global burden of viral diseases and bring us closer to more effective, personalized, and more readily available antiviral healthcare.

15 May 2025
Verified
Book Chapter
Closed access
RPRaveesha Peeriga
Raveesha Peeriga
Krishnaveni ManuboluKrishnaveni Manubolu
Krishnaveni Manubolu
Because of the constantly increasing market for herbal medicines, there has been a demand by consumers for natural, plant-based health solutions, thereby making most of the markets grow at the rate of increased demand. However, quality, safety and efficacy of these products are still huge challenges, mainly because of variability of traditional practices and absence of uniform regulatory standards in various regions. Hence, the World Health Organization (WHO) has devised specific good manufacturing practices (GMP) guidelines for herbal medicines to meet strict safety and quality standards. In this chapter, an in-depth analysis of WHO GMP guidelines for herbal medicines with a focus on areas such as monitoring systems, quality control, documentation, standardization and raw material sourcing is done. These guidelines also suggest proper handling and storage to avoid contamination and the use of validated procedures in the manufacturing process. The chapter concludes with prospects for further improvement in the regulation and quality assurance of herbal medicines so that potential herbal therapies can be used in modern healthcare. <!----> <!----> <!----> <!---->